mind you at the end of the day fda approval and when the product actually starts to get to market does matter, although while on that front you cant probably shave a bit off my estimate above, i assume further dilution, assume a whopping 40% discount rate and US income only. Europe market is pretty big too (Grunenthals target markets, and latin america i believe).
mind you at the end of the day fda approval and when the product...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.5¢ |
Change
-0.010(1.29%) |
Mkt cap ! $873.4M | |||
| Open | High | Low | Value | Volume |
| 76.5¢ | 80.3¢ | 76.0¢ | $5.022M | 6.472M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 424489 | 76.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.5¢ | 3903 | 1 |
View Market Depth
| Last trade - 16.10pm 19/04/2024 (20 minute delay) ? |
|
|||||
|
Last
76.5¢ |
Change
-0.010 ( 1.20 %) |
||||
| Open | High | Low | Volume | ||
| 78.0¢ | 80.0¢ | 76.0¢ | 2064486 | ||
| Last updated 15.59pm 19/04/2024 ? | |||||
| MSB (ASX) Chart |